TCL Archive NCI funds four radiation oncology cancer disparities research partnerships. October 10, 2003
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive FDA Reaction to DCT Proposals ‘Positive,’ But Chabner, Wittes ‘Disappointed’ In That Response June 17, 1988
TCL Archive FDA Commissioner Mark McClellan tells NCI audience that science is far from eliminating cancer as a threat. February 6, 2004
